Pharmacokinetics and pharmacodynamics of nanoparticulate drug delivery / Jayvadan K. Patel, Yashwant V. Pathak, editors.
Patel, Jayvadan K.; Pathak, Yashwant Vishnupant.
2022
RS199.5
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Pharmacokinetics and pharmacodynamics of nanoparticulate drug delivery / Jayvadan K. Patel, Yashwant V. Pathak, editors.
ISBN
9783030833954 (electronic bk.)
303083395X (electronic bk.)
3030833941
9783030833947
DOI
https://doi.org/10.1007/978-3-030-83395-4
Publication Details
Cham, Switzerland : Springer, 2022.
Language
English
Description
1 online resource
Item Number
10.1007/978-3-030-83395-4 doi
Call Number
RS199.5
Dewey Decimal Classification
615/.6
Summary
A reference is needed that addresses the recent progress in aspects of PK/PD methods and developments of nanoparticles for novel drug delivery systems. No other consolidated published reference discusses the PK/PD study of nanoparticle drug delivery systems. This book discusses the advantages of nanoparticle drug delivery systems (NPDDS) in enhancing the pharmacokinetics of many drugs that are not easily metabolized or that obtain the desired therapeutic effect with minimum toxicity. The authors provide an overview of biodistribution with a focus on polymer and lipid nanoparticles. This thorough reference is divided into three parts: Modelling, Specific carries and their potential to treat specific diseases.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed March 21, 2022).
Added Author
Patel, Jayvadan K.
Pathak, Yashwant Vishnupant.
Available in Other Form
Print version: 9783030833947
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Part 1-Modelling of PK/PD for NPDDS
Introduction to Nanoparticulate Drug Delivery Systems
Nanoparticle Properties Affecting Pharmacokinetics of NPDDS
Models Used for Biopharmaceutical Evaluation of NPDDS
Models Used in the Pharmacokinetic Evaluation of NPDDS
Models Used in the Pharmacodynamic Evaluation of NPDDS
Preclinical Animal Models For Experimental Design of Pharmacokinetic Studies of NPDDS
Pharmacokinetic Modelling Program (PKMP)
Part 2-PK/PD for Specific Nanocarriers
Pharmacokinetic and Pharmacodynamics of Liposomal Nanoparticles
Pharmacokinetics of Polymer Matrix Drugs (NPDDS)
Pharmacokinetics of Long-Circulating NPDDS
Metallic Gold Nanoparticles in vivo Pharmacokinetics and X-ray Contrast imaging Studies
Muco-adhesive NPDDS In Vitro and Pharmacokinetics Studies
Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
PKPD of PLGA-PEG-PLGA Triblock CoPolymeric Micelles
Part 3-PKPD in Diseased Conditions for NPDDS
Bridging Bio-Nanoscience and Cancer Nanomedicine
Clearance Pathways and Tumor Targeting of Imaging Nanoparticles for Diagnostics
PLGA Nanoparticles for Oral Delivery-Nephrotoxicity and Pharmacokinetic Studies
Pharmacokinetics of Nanoparticle Systems for Pulmonary Delivery
In vivo Biodistribution and Pharmacokinetic Studies of NPDDS for Brain Targeting
Enhanced Bioavailability and Intestinal Uptake Nanoparticles After Oral Delivery
Nanoparticle Pharmacokinetic Profiling In Vivo Using Magnetic Resonance Imaging.

Browse Subjects

Show more subjects...

Statistics

from
to
Export